Use of Fibrates and Cancer Risk: A Systematic Review and Meta-Analysis of 17 Long-Term Randomized Placebo-Controlled Trials

BACKGROUND: Fibrates comprise a class of well-established antilipidemic agents that significantly reduce cardiovascular events. Given the concerns of cancer with fibrate therapy, we undertook a systematic review and meta-analysis to investigate the effects of fibrates on cancer outcomes. METHODS: We...

Descripción completa

Detalles Bibliográficos
Autores principales: Bonovas, Stefanos, Nikolopoulos, Georgios K., Bagos, Pantelis G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3446944/
https://www.ncbi.nlm.nih.gov/pubmed/23028888
http://dx.doi.org/10.1371/journal.pone.0045259

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3446944/
https://www.ncbi.nlm.nih.gov/pubmed/23028888
http://dx.doi.org/10.1371/journal.pone.0045259

Ejemplares similares